Stay updated on Pembrolizumab for ALL MRD Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Recruitment status on the study page is updated to indicate no further participant enrollment ('No longer looking for participants'), and several new navigation/help sections are added (How to Read a Study Record, Common Questions, How to Join a Study). A minor formatting change to the Intervention/Treatment heading and a new revision stamp 'Revision: v3.6.0' are also included.
    Difference
    0.5%
    Check dated 2026-06-13T00:58:29.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a system or site-wide update to the platform.
    Difference
    0.1%
    Check dated 2026-06-05T21:38:01.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The revision label was updated from v3.5.3 to v3.5.4, indicating a deployment or maintenance update to the site. There is no visible change to study content or user-facing features on this page.
    Difference
    0.1%
    Check dated 2026-05-15T14:44:39.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from v3.5.2 to v3.5.3, reflecting a site/platform release rather than any change to the clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-24T05:57:14.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:40:35.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added 'Acute lymphoid leukemia' as a condition term and added a 'Genetic and Rare Diseases Information Center' resource in the Resources section.
    Difference
    0.2%
    Check dated 2026-04-02T15:32:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.